What’s New

The CAR-TCR field continues to evolve rapidly, and to support your ever-changing needs the CAR-TCR Summit Europe is back, bigger and better than ever before.

What's new for 2020?

3 Tracks of Dedicated Content

Bursting with technical level content, this agenda will address the technical limitations that are preventing your CAR or TCR therapy from becoming a reality. Join us with your team to divide and conquer the 3 tracks spanning translation, manufacture and commercial development to take away lessons learnt from the trail blazers breaking the norms.

Over 40 World-Class Speakers

This is a must-attend forum to network and collaborate with pioneers from Celyad, Juno Therapeutics, GlaxoSmithKline, NHS, Novartis and many more!

9 Discussion-Based Workshops

Providing you with ample opportunity to drill deeper into the greatest hurdles in the space, these intimate and engaging workshop sessions are your opportunity to enhance your learning and ask your own specific questions to take away tangible insights to advance your work.

2 Focused Agendas

Operationally running CAR and TCR trials in Europe is a great challenge in regard to setting up effective infrastructure, managing toxicity and supporting patient education. Another huge area of focus is to improve trafficking of CAR and TCRs to the solid tumour site, overcoming the suppressive environment.

Therefore, it is vital to attend this Focus Day to network exclusively with those working to overcome these hurdles.

CAR-TCR EU Testimonial Banners